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Bacteria of the genus Brucella infect a range of vertebrates causing a worldwide
extended zoonosis. The best-characterized brucellae infect domestic livestock,
behaving as stealthy facultative intracellular parasites. This stealthiness depends on
envelope molecules with reduced pathogen-associated molecular patterns, as revealed
by the low lethality and ability to persist in mice of these bacteria. Infected cells are
often engorged with brucellae without signs of distress, suggesting that stealthiness
could also reflect an adaptation of the parasite metabolism to use local nutrients
without harming the cell. To investigate this, we compared key metabolic abilities of
Brucella abortus 2308 Wisconsin (2308W), a cattle biovar 1 virulent strain, and B. suis
513, the reference strain of the ancestral biovar 5 found in wild rodents. B. suis 513
used a larger number of C substrates and showed faster growth rates in vitro, two
features similar to those of B. microti, a species phylogenomically close to B. suis
biovar 5 that infects voles. However, whereas B. microti shows enhanced lethality
and reduced persistence in mice, B. suis 513 was similar to B. abortus 2308W in
this regard. Mutant analyses showed that B. suis 513 and B. abortus 2308W were
similar in that both depend on phosphoenolpyruvate synthesis for virulence but not
on the classical gluconeogenic fructose-1,6-bisphosphatases Fbp-GlpX or on isocitrate
lyase (AceA). However, B. suis 513 used pyruvate phosphate dikinase (PpdK) and
phosphoenolpyruvate carboxykinase (PckA) for phosphoenolpyruvate synthesis in vitro
while B. abortus 2308W used only PpdK. Moreover, whereas PpdK dysfunction causes
attenuation of B. abortus 2308W in mice, in B. suis, 513 attenuation occurred only in the
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double PckA-PpdK mutant. Also contrary to what occurs in B. abortus 2308, a B. suis
513 malic enzyme (Mae) mutant was not attenuated, and this independence of Mae and
the role of PpdK was confirmed by the lack of attenuation of a double Mae-PckA mutant.
Altogether, these results decouple fast growth rates from enhanced mouse lethality in
the brucellae and suggest that an Fbp-GlpX-independent gluconeogenic mechanism
is ancestral in this group and show differences in central C metabolic steps that may
reflect a progressive adaptation to intracellular growth.
Keywords: Brucella, metabolism, gluconeogenesis, pyruvate phosphate dikinase, phosphoenolpyruvate
carboxykinase, malic enzyme, isocitrate lyase
INTRODUCTION
In order to survive and efficiently replicate, pathogens need to
adjust their metabolism to the nutrients available in their hosts.
This is the case of the brucellae, a group of Gram-negative
bacteria that infect a wide range of vertebrates (Whatmore,
2009; Zheludkov and Tsirelson, 2010; Soler-Lloréns et al., 2016;
Al Dahouk et al., 2017) and include facultative intracellular
pathogens causing brucellosis, a worldwide distributed zoonosis.
Taxonomically, these bacteria are grouped currently in a single
genus with up to 12 closely related species1, some of which
were divided long ago into biovars according to phenotypic
criteria (Alton et al., 1988). Recent studies show that most
brucellae form a core group, which includes the “classical” species
as well as more recent isolates from a variety of mammals,
separated from several early diverging brucellae, which in turn
are close to environmental bacteria and opportunistic pathogens
of the α-2 Proteobacteria (Soler-Lloréns et al., 2016; Al Dahouk
et al., 2017). Thus far, the core brucellae that infect domestic
ruminants (Brucella abortus and B. melitensis) and swine (B. suis
biovars 1, 2, and 3) have deserved greater attention undoubtedly
because of their early identification and great impact on public
health and animal production. Even though these three species
are often described as fastidious because of their slow growth
and complex requirements for primary isolation (peptone-yeast
extract media, often supplemented with serum), under laboratory
conditions the strains investigated are auxotrophic for a few
vitamins and, but for some strains that seem to require some
amino acids (Plommet, 1991; see also section “Discussion”),
they grow on mineral salts with glutamate-lactate-glycerol or
glucose (Gerhardt and Wilson, 1948; Plommet, 1991; Barbier
et al., 2018). However, there is only limited information on the
substrates and pathways in their replicative niche, a vacuole
connected to ER cisternae and the outer nuclear membrane
(Pizarro-Cerdá et al., 1998; Starr et al., 2008; Ronneau et al.,
2014; Zúñiga-Ripa et al., 2014; Barbier et al., 2018; Sedzicki et al.,
2018).
The central C metabolism pathways of Brucella have been
reviewed recently (Barbier et al., 2018). Radiorespirometric and
biochemical analyses show that B. suis 1330 (reference strain of
biovar 1), B. melitensis 16M (reference strain of biovar 1) and
B. abortus 2308 [biovar 1, National Animal Disease Laboratory
(Ames, IA, United States)] and S19 (attenuated vaccine strain)
1http://www.bacterio.net/-allnamesac.html
can split hexoses into trioses (Robertson and McCullough, 1968).
However, there is no phosphofructokinase (Pfk; Figure 1) and
glycolysis [i.e., the Embden–Meyerhof–Parnas (EMP)] pathway
is thus interrupted. Similarly, although all genes of the Entner–
Doudoroff (ED) pathway are present, the dehydratase (Edd)
activity could not be detected in the strain tested (S19).
Accordingly, the pentose shunt would be the only route that
can provide phosphorylated trioses for subsequent oxidation
in the tricarboxylic acid (TCA) cycle (Barbier et al., 2018;
Figure 1). Surprisingly, a B. abortus 2308 Wisconsin (2308W; see
Supplementary Table S1 and Suárez-Esquivel et al., 2016) double
fbp and glpX mutant (the canonical gluconeogenic fructose-
1,6-bisphosphatase genes; Figure 1) grows in gluconeogenic
media, albeit at a markedly reduced rate (Zúñiga-Ripa et al.,
2014). Moreover, attenuation in BALB/c mice was observed for
pyruvate phosphate dikinase (PpdK) and malic enzyme (Mae)
mutants but not for mutants in Fbp, GlpX, phosphoenolpyruvate
carboxykinase (PckA) or isocitrate lyase (AceA; glyoxylate shunt)
(Figure 1). These observations suggest that B. abortus 2308W
is endowed with unconventional gluconeogenic enzymes and
that, during infection, has access to a limited supply of 6 and
5 C substrates that is compensated through anaplerotic routes
by TCA intermediates without a critical role of the glyoxylate
shunt.
Phylogenomic analyses show that the core brucellae are less
uniform than previously assumed on the basis of DNA:DNA
hybridization (Verger et al., 1985). While all B. abortus and
B. melitensis biovars group into two clades, the five recognized
biovars of B. suis show phylogenomic diversity inconsistent with
their grouping into a single species (Moreno et al., 2002; Scholz
et al., 2008; Whatmore, 2009; Al Dahouk et al., 2012) and a very
wide host range. Biovars 1 and 3 of this nominal species infect
swine in the countries of America, Asia, and Europe; biovar 2,
swine and hares in Europe; biovar 4, Artic and Northern Eurasia
reindeers; and biovar 5 were isolated from species of wild rodents
in Transcaucasia some 30 years ago (Zheludkov and Tsirelson,
2010). Since B. suis biovar 5 (reference strain 513) is closer to
the ancestral brucellae (Whatmore, 2009; Al Dahouk et al., 2017),
in this work, we examined whether it shares with B. abortus
some relevant nutritional characteristics and steps of the central
C metabolism, an information that may help to identify pathways
that are conserved and may thus be important in the intracellular
life of core brucellae. Here, we report similarities and differences
and discuss their potential significance in the lifestyle of these
bacteria. The differences and similarities between B. suis 513
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FIGURE 1 | Central C metabolic network of Brucella (adapted from Zúñiga-Ripa et al., 2014). The metabolic network includes complete pentoses phosphate,
Entner–Doudoroff and gluconeogenesis pathways, as well as a complete tricarboxylic acid cycle including a glyoxylate shunt. The Embden–Meyerohof–Parnas
pathway is interrupted due to the lack of phosphofructokinase (Pfk). Black dashed arrows and italics indicate steps for which no putative genes can be
identified in Brucella Gray arrows and gray font indicate peripheral pathways. Metabolites: 1,3,bPG, 1,3-bisphosphoglycerate; KDPG, 2-keto-3-
deoxy-phosphogluconate; 2PG, 2-phosphoglycerate; 3PG, 3-phosphoglycerate; 6PGL, 6-P-gluconolactone; 6PG, 6-phosphogluconate; AcCoA, acetyl-coenzyme
A; AKG, alpha-ketoglutarate; CIT, citrate; ICIT, isocitrate; DHAP, dihydroxyacetone-phosphate; E4P, erythrose-4-phosphate; F1,6bP, fructose-1,6-bisphosphate; F6P,
fructose-6-phosphate; FUM, fumarate; G6P, glucose-6-P; GAP, glyceraldehyde-3-phosphate; G3P, glycerol-3-phosphate; GLX, glyoxylate; MAL, malate; OAA,
oxaloacetate; PEP, phosphoenolpyruvate; PYR, pyruvate; R5P, ribose-5-P; RIB5P, ribulose-5-P; S7P, sedoheptulose-7-P; SUC, succinate; SucCoA,
succinyl-coenzyme A; X5P, xylulose-5-P. Enzymes: Edd, 6-phospho-D-gluconate dehydratase; Gnd, 6-phosphogluconate dehydrogenase; Pgl,
6-phosphogluconolactonase; Acs, acetyl-coenzyme A synthetase; Acn, aconitate hydratase; Akgdh, alpha-ketoglutarate dehydrogenase; GltA, citrate synthase;
eno, enolase; Fbp, GlpX, fructose-1,6-bisphosphatase; Fba, fructose bisphosphate aldolase; Fum, fumarase; Zwf, glucose-6-phosphate dehydrogenase; Pgi,
glucose-6-phosphate isomerase; Gdh, glutamate dehydrogenase; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; GlpD, glycerol-3-phosphate
dehydrogenase; GlpK, glycerol kinase; Idh, isocitrate dehydrogenase; AceA, isocitrate lyase; Eda, 2-dehydro-3-deoxy-phosphogluconate aldolase; Ldh, lactate
dehydrogenase; Mdh, malate dehydrogenase; AceB, malate synthase; Mae, malic enzyme; PckA, phosphoenolpyruvate carboxykinase; Ppc, phosphoenolpyruvate
carboxylase; Pps, phosphoenolpyruvate synthase; Pfk, phosphofructokinase; Pgk, phosphoglycerate kinase; Gpm, phosphoglycerate mutase; Oad, pyruvate
carboxykinase; Pyc, pyruvate carboxylase; Pdh, pyruvate dehydrogenase; Pyk, pyruvate kinase; PpdK, pyruvate phosphate dikinase; Rpi, ribose-5-phosphate
isomerase; Rpe, ribulose-5-phosphate-3-epimerase; Sdh, succinate dehydrogenase; Stk, succinyl-coenzyme A synthethase; Tal, transaldolase; Tkt, transketolase;
Tpi, triose phosphate isomerase.
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and B. microti (a species isolated more recently from Microtus
arvalis), noticed in the course of this study are also discussed.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The bacterial strains and plasmids used in this study are listed
in Supplementary Table S1. All Brucella were handled under
BSL-3 containment. The strains resulting from the genetic
manipulations described below were characterized according
to standard Brucella typing procedures (Alton et al., 1988):
colonial morphology after 3 days of incubation at 37◦C, crystal
violet exclusion, urease, acriflavine agglutination, sensitivity to
Tb, Wb, Iz, and R/C phages, agglutination with anti-A and
anti-M monospecific sera, CO2 and serum dependence, and
susceptibility to thionine blue, fuchsine, and safranin. Bacteria
were routinely grown in standard Peptone-Glucose [Biomerieux;
bio-Trypcase (17 g/L), bio-Soyase (3 g/L), Glucose (2.5 g/L), NaCl
(5 g/L), K2HPO4 (2.5 g/L)] or this media supplemented with
agar. The Peptone-Yeast Extract medium used was composed
of bacto tryptone (16 g/L), yeast extract (10 g/L), and NaCl
(5 g/L) (all from BD Difco). The following antibiotics were used
at the indicated concentrations: kanamycin (Km; 50 µg/mL),
polymyxin (Pmx; 1.5 µg/mL), and/or chloramphenicol (Cm;
20 µg/mL) (all from Sigma). When needed, media was
supplemented with 5% sucrose. All strains were stored in
skimmed milk at−80◦C (Scharlau).
To study the phenotype of the metabolic mutants constructed,
the defined medium of Gerhardt (glutamate-lactate-glycerol) was
used (Gerhardt and Wilson, 1948). The components for 1 L
medium are: glycerol (30 g), lactic acid (5 g), glutamic acid (1.5 g),
thiamine (0.2 mg), nicotinic acid (0.2 mg), pantothenic acid
(0.04 mg), biotin (0.0001 mg), K2HPO4 (10 g), Na2S2O3·5H2O
(0.1 g), MgSO4 (10 mg), MnSO4 (0.1 mg), FeSO4 (0.1 mg),
and NaCl (7.5 g). The pH was adjusted to 6.8–7. In addition,
a modification of Plommet’s medium was also used (Plommet,
1991; Barbier et al., 2014) and 1 L of this medium is composed of
thiamine (0.2 g), nicotinic acid (0.2 g), pantothenic acid (0.07 g),
biotin (0.1 mg), K2HPO4 (2.3 g), KH2PO4 (3 g), Na2S2O3 (0.1 g),
MgSO4 (0.01 g), MnSO4 (0.1 mg), FeSO4 (0.1 mg), NaCl (5 g),
(NH4)2SO4 (0.5 g), and 1 g/L of substrate. When glutamic acid
was used as nitrogen and C source (NH4)2SO4 was not added.
DNA Manipulations
Genomic sequences of the different Brucella species were
obtained from the database National Center for Biotechnology
Information (NCBI) and Kyoto Encyclopedia of Genes and
Genomes (KEGG). Searches for DNA and protein homologies
were carried out using NCBI BLAST (Altschul et al., 1990).
Sequence alignments were performed with Clustal Omega
(Goujon et al., 2010; Sievers et al., 2011). Primers were
synthesized by Sigma (Haverhill, United Kingdom). DNA
sequencing analysis was performed by the Servicio de
Secuenciación de CIMA (Centro de Investigación Médica
Aplicada, Universidad de Navarra, Pamplona, Spain). Restriction
modification enzymes were used under the conditions
recommended by the manufacturer. Plasmid and chromosomal
DNA were extracted with QIAprep Spin Miniprep (Qiagen) and
Ultraclean Microbial DNA Isolation kit (Mo Bio Laboratories),
respectively. When needed, DNA was purified from agarose gels
using QIAquick Gel Extraction Kit (Qiagen).
Mutagenesis
Construction of the in-frame deletion mutants Bs51fbp,
Bs51glpX, Bs51fbp1glpX, Bs51pckA, Bs51ppdK, Bs51pckA
1ppdK, Bs51mae, Bs51mae1pckA, and Bs51aceA was done
using previously described plasmids and strategy (Zúñiga-Ripa
et al., 2014).
Bs51BMI_I149 (and Bs51maeBs51BMI_I149) was
obtained using the plasmid pAZI-25 constructed in
this work. First, two PCR fragments were generated:
oligonucleotides BMI_I149-F1 (5′-GGTTCCGGCTCTTTCTCT
TC-3′) and BMI_I149-R2 (5′-AAAGTCGAGCGCTTCC
TTCT-3′) amplified a 266 bp fragment including codons
1–31 of BMI_I149, as well as 161 bp upstream of the
BMI_I149 start codon; oligonucleotides BMI_I149-F3
(5′-AGAAGGAAGCGCTCGACTTTAACCCGAAACTGATGG
AACA-3′) and BMI_I149-R4 (5′-TGGACTTGCGATGACAGA
AC-3′) were used to amplify a 356 bp fragment including the
last 240 bp of BMI_I149. A third PCR joined the two fragments
together using oligonucleotides BMI_I149-F1 and BMI_I149-R4
for amplification and the complementary regions between
BMI_I149-R2 and BMI_I149-F3 for overlapping. The resulting
fragment, containing the BMI_I149 deletion allele, was cloned
into pCR2.1 (Invitrogen). After sequence verification, the insert
was excised as a BamHI–XbaI fragment and cloned in a pJQKm
suicide vector (Scupham and Triplett, 1997). The acquisition of
this vector by Brucella after mating with conjugative Escherichia
coli S17 λpir was selected by Km and Pmx resistance. The loss
of the plasmid concomitant with either a deletion or a return to
wild type phenotype was then selected on sucrose. The resulting
colonies were screened by PCR with primers BMI_I149-F1
and BMI_I149-R4 which amplified a fragment of 622 bp in the
mutant and a fragment of 2599 bp in the revertant strain. To
check the mutation, an internal primer (BMI_I149-R5) which
hybridized in the non-deleted region was used.
For complementation, the plasmid pAZI-19 previously
described (Zúñiga-Ripa et al., 2014) was used.
Growth Curves
Growth curves were obtained using a Bioscreen C (Lab Systems)
apparatus. To avoid carry over of media by the inoculum and
lengthy lag phases, inocula were obtained from bacteria grown
in test media as follows. First, the strains were inoculated into
10 mL of peptone-glucose in a 50 mL flask and incubated
at 37◦C with orbital shaking for 18 h. Then, these bacteria
were harvested by centrifugation, resuspended in 10 mL of the
test medium (peptone-glucose, peptone-yeast extract, glutamate-
lactate-glycerol, glutamate, or lactate) at an OD600 nm of 0.1,
and incubated at 37◦C with orbital agitation for 18 h. These
exponentially growing bacteria were harvested by centrifugation,
resuspended at an OD600 nm of 0.1 in the test medium, dispensed
as technical replicates in Bioscreen multiwell plates (200 µL/well;
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starting OD of 0.05 in the Bioscreen apparatus) and cultivated
for 5 days with continuous shaking at 37◦C. Absorbance values
at 420–580 nm were automatically recorded at 30-min intervals.
All experiments were repeated at least three times. Controls with
medium and no bacteria were included in all experiments.
Cell Culture and Infection
RAW 264.7 murine macrophages (ATCC TIB-71) were routinely
cultured in Dulbecco’s Modified Eagle Medium (DMEM;
Gibco) with 10% (vol/vol) heat-inactivated fetal bovine serum
(Gibco), 1% (vol/vol) L-glutamine (200 nM; Sigma-Aldrich),
and 1% (vol/vol) non-essential amino acids (Gibco). Cells were
maintained at 37◦C with a 5% CO2 atmosphere.
Infections were performed as previously described (Zúñiga-
Ripa et al., 2014). Briefly, cells were seeded in 24-well plates
at an appropriate density (1 × 105 cells/well) and infected
24 h later with a multiplicity of infection (MOI) of 50:1. Cells
were centrifuged at 400 × g, for 10 min at 4◦C before being
incubated for 15 min at 37◦C with 5% CO2, washed with fresh
medium and incubated for 90 min with medium containing
100 µg/mL of gentamycin. The medium was then replaced by
a fresh one containing 25 µg/mL of this antibiotic. At each
time point, cells were washed three times with 100 mM PBS
(pH 7) before processing, lysed with 0.1% (v/v) Triton X-100
in PBS, and plated on peptone-glucose-agar to determine the
number of intracellular bacteria. All experiments were performed
in triplicate and results are expressed as means and standard
errors (n = 3) of individual log10 CFU/well. The attenuated
B. abortus virB mutant was used as a control (Sieira et al.,
2000).
Virulence Assays in Mice
Seven-week-old female BALB/c mice (Harlan Laboratories,
Bicester, United Kingdom) were accommodated in the facilities of
Centro de Investigación y Tecnología Agroalimentaria de Aragón
(CITA; Registration code ES502970012025) for 2 weeks before
and during the experiments, with water and food ad libitum
under P3 biosafety containment conditions. The animal handling
and other procedures were in accordance with the current
European (directive 86/609/EEC) and Spanish (RD 53/2013)
legislations, supervised by the Animal Welfare Committee of the
CITA (2014-20).
For each strain, inoculum was prepared from cultures
on peptone-glucose-agar at 37◦C. Bacteria were harvested
in 10 mM PBS (pH 7), suspended in this diluent to the
appropriate concentration and approximately 5 × 104 CFU
in 0.1 mL administered to each mouse intraperitoneally
(exact doses were retrospectively assessed). For each strain,
mice (n = 5 per group) were inoculated and the CFU in
spleens was determined at different weeks post-inoculation.
Mice were anesthetized by intraperitoneal injection and
sacrificed by cervical dislocation; spleens were isolated,
weighted, homogenized in 9 vol of PBS and CFU counted
on peptone-glucose-agar. The identity of the spleen isolates
was confirmed by PCR at several points during the infection
process. The individual data were normalized by logarithmic
transformation, and the mean log10 CFU/spleen values and
the standard deviation (n = 5) were calculated. Statistical
significance was evaluated using one-way ANOVA followed
by Dunnett’s test (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001,
∗∗∗∗p< 0.0001).
RESULTS
Brucella suis 513 (Reference Strain of
Biovar 5) Uses a Broad Range of
Substrates as the Only C Source but It Is
Not Prototrophic for Vitamins
Since the growth characteristics and requirements of B. suis
513 are practically unknown, we first examined the ability of
this reference strain to grow on common C6, C5, C4, and C3
substrates as the only C source using the vitamins–mineral salts
(with ammonium sulfate as N source when necessary) basal
medium of Plommet (Plommet, 1991; Table 1 and Figures 2–5).
We found that the range of substrates used by B. suis 513 as the
only C source was broader than that of B. abortus 2308W (Suárez-
Esquivel et al., 2016). Remarkably, whereas B. suis 513 was able
to grow efficiently on lactate or glutamate, B. abortus 2308W
was not (Table 1 and Figures 3–5) and required at least one
additional C source (i.e., glutamate-lactate or glutamate-glycerol;
not shown and Zúñiga-Ripa et al., 2014). These differences
suggested that B. suis 513 is more prototrophic than B. abortus
2308W (see section “Discussion”), and thus we examined the
vitamin requirements of B. suis 513. We found that B. suis 513
TABLE 1 | Growth of B. abortus 2308W and B. suis 513 on single C6, C4, and
C3 compounds as the only C source1.
Yield (OD600 nm)2
C source B. abortus 2308W B. suis 513
C6
Glucose 0.00 0.75
Fructose 0.00 0.25
Gluconate 0.00 0.00
Mannose 0.00 0.85
Fucose 0.00 0.60
Inositol 0.00 0.00
C5
Ribose 0.11 0.90
Xilose 0.19 0.85
Glutamate 0.00 0.60
C4
Succinate 0.00 0.00
Erythritol 0.70 0.90
C3
Glycerol 0.00 0.00
Lactate 0.00 0.60
Pyruvate 0.00 0.70
1C sources (1 g/L) were added to the vitamin-salt broth of Plommet’s medium
(see section “Materials and Methods”). 2Yields correspond to the stationary phase
(obtained at different times depending on the C source).
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FIGURE 2 | Growth curves in glutamate-lactate-glycerol, peptone-yeast extract, and peptone-glucose of B. abortus 2308W, B. suis 513, and B. microti CCM4915.
Each point represents the mean ± standard error (error bars are within the size of the symbols) of optical density (OD) values of triplicate samples. The experiment
was repeated three times with similar results.
required nicotinic acid and thiamine (Supplementary Figure S1),
being in this regard not different from B. abortus, B. melitensis, or
the B. suis biovars previously studied, all of which require at least
these two vitamins (Koser et al., 1941; Koser and Wright, 1942;
McCullough and Dick, 1942a,b; McCullough et al., 1946).
Brucella suis 513 Shows Faster Growth
Rates Than B. abortus 2308W in
Gluconeogenic Media That Do Not
Depend on Fbp and GlpX
Since the above observations show that we could probe some
aspects of the central C pathways of B. suis 513 using simple
defined media, we compared first the growth of B. suis 513
with B. abortus 2308W (slow growing) and B. microti CCM4915
(usually described as fast growing) under gluconeogenic
conditions (Gerhardt’s medium, containing glutamate, lactate,
glycerol, mineral salts, and vitamins; henceforth glutamate-
lactate-glycerol). As can be seen in Figure 2, the growth curves
suggested higher growth rates for B. suis 513 and B. microti
CCM4915 depending upon the medium. In peptone-yeast
extract, a rich but still gluconeogenic medium where growth
factors are abundant, B. suis 513 and B. microti CCM4915
displayed shorter generation times and much higher yields than
B. abortus 2308W. These differences almost disappeared when
peptone was combined with glucose (Figure 2). Taken together,
these results suggest that B. suis 513 and B. microti CCM4915,
on one hand, and B. abortus 2308W, on the other, differ in
gluconeogenic abilities, a hypothesis that was examined in the
experiments described below.
The brucellae carry homologs of the two canonic fructose-
1,6-bisphosphatases (Fbp and GlpX) on which the gluconeogenic
pathway depends. Consistent with our previous report (Zúñiga-
Ripa et al., 2014), the simultaneous dysfunction of Fbp and
GlpX did not affect the growth of B. abortus 2308W in
peptone-glucose and impaired but did not abrogate its growth
in glutamate-lactate-glycerol (Figure 3). In contrast, growth
of single (Bs51fbp or Bs51glpX) or double (Bs51fbp1glpX)
bisphosphatase mutants of B. suis 513 was not compromised to
any extent in glutamate-lactate-glycerol (Figure 3). Since B. suis
513 grew on lactate or glutamate as the sole C source, we also
tested the mutants on these gluconeogenic substrates. We found
that the ability to grow was not affected on lactate, and only
slightly for Bs51fbp and Bs51fbp1glpX but not for Bs51glpX on
glutamate (Figure 3).
Brucella suis 513 and B. abortus 2308W
Differ in Key Steps Connecting
Phosphoenolpyruvate and TCA
We then investigated whether growth of B. suis 513 in
complex and gluconeogenic media depends on the steps
catalyzed by PpdK (phosphoenolpyruvate↔ pyruvate) and PckA
(oxaloacetate→ phosphoenolpyruvate) (Figure 1). As observed
for B. abortus 2308W (Figure 4 and Zúñiga-Ripa et al., 2014),
deletion of ppdK (Bs51ppdK) impaired the growth of B. suis
513 on glutamate-lactate-glycerol but not on peptone-glucose
(Figure 4). On the other hand, deletion of pckA had no effect in
B. suis 513 (mutant Bs51pckA; Figure 4) or in B. abortus 2308W
(Zúñiga-Ripa et al., 2014). Although these observations could be
interpreted to mean that, like in B. abortus 2308W (Zúñiga-Ripa
et al., 2014), PckA is not functional and gluconeogenesis depends
only on PpdK in B. suis 513, we found this hypothesis not to be
true because growth on glutamate-lactate-glycerol was abrogated
in a double Bs51pckA1ppdK mutant (Figure 4), indicating that
PckA is active in this strain. These results are in keeping with
the fact that while B. abortus 2308W pckA carries a frameshift
that generates a premature stop codon (TGA) at position 1474–
1476, the orthologous codon in B. suis 513 is TGG (tryptophan)
(a BLAST search did not reveal any other copy of pckA in the
B. abortus 2308W genome).
We further explored the role of PpdK and PckA by
growing Bs51ppdK, Bs51pckA, and Bs51pckA1ppdK on lactate
or glutamate. But for the expected reduction in growth
yields, the results obtained in glutamate paralleled those
in glutamate-lactate-glycerol (Figure 4), confirming that the
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FIGURE 3 | Growth curves in peptone-glucose, glutamate-lactate-glycerol,
glutamate, and lactate of B. suis 513 and mutants Bs51fbp, Bs51glpX, and
Bs51fbp1glpX, and B. abortus 2308W and mutant BAB1fbp1glpX. Each
point represents the mean ± standard error (error bars are within the size of
the symbols) of an experiment performed in technical triplicates.
The experiment was repeated three times with similar results.
steps catalyzed by PckA and PpdK set a clear difference in
the metabolism of B. abortus 2308W and B. suis 513 in
gluconeogenic substrates. Interestingly, growth of Bs51ppdK
in lactate was unaffected. As the brucellae lack gluconeogenic
phosphoenolpyruvate synthase (Pps; Figure 1; Barbier et al.,
2018), this result means that TCA cycle intermediates derived
from the pyruvate obtained from lactate (Figure 1) can sustain
gluconeogenesis. Since this could implicate a malic enzyme
(Mae in Figure 1), we investigated the mae homologs of
B. suis 513.
First, we identified a clear homolog of B. abortus 2308W
mae in B. suis 513, which is also a homolog of B. microti
FIGURE 4 | Growth curves in peptone-glucose, glutamate-lactate-glycerol,
glutamate, and lactate of B. suis 513 and mutants Bs51pckA, Bs51ppdK,
and Bs51pckA1ppdK, and B. abortus 2308W and mutant BAB1ppdK. Each
point represents the mean ± standard error (error bars are within the size of
the symbols) of an experiment performed in technical triplicates.
The experiment was repeated three times with similar results.
(strain CCM4915) BMI_I1020. Although in B. microti there is
a second ORF annotated as mae (BMI_I149), its B. suis 513
counterpart lacks a thymine at position 1153 that originates
a frameshift that could compromise the functionality of the
protein. Thus, we started studying the role of the first mae
identified. Consistent with the presence of an active enzyme
furnishing pyruvate from oxaloacetate (Figure 1), this Bs51mae
mutant displayed a reduction in growth on glutamate but
not on lactate, a phenotype similar to that of its B. abortus
2308W counterpart but for the expected differences in growth
rates/yields (Figure 5). Moreover, growth on glutamate was
abrogated in a double Bs51mae1pckA mutant (Figure 5), the
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expected result if both Mae and PckA are active and the former
acts in tandem with PpdK in gluconeogenesis (Figure 1). On the
other hand, these mutants grew normally on lactate (Figure 5),
as expected if lactate provides pyruvate for both gluconeogenesis
and TCA reactions (Figure 1). Indirectly, the lack of growth of
the double mutant on glutamate was coherent with the possibility
that the frameshift in the BMI_I149 ortholog results in a non-
functional protein, and we confirmed this using a double mutant
in the B. suis 513 orthologs of BMI_I1020 (mae) and BMI_I149.
This double mutant displayed the same growth characteristics
as the single Bs51mae (Supplementary Figure S2), strongly
suggesting that the protein encoded by the BMI_I149 homolog
lacks Mae activity in B. suis 513.
The results presented above show that B. suis 513
converts malate to pyruvate via Mae, and oxaloacetate to
FIGURE 5 | Growth curves in peptone-glucose, glutamate-lactate-glycerol,
glutamate, and lactate of B. suis 513 and mutants Bs51mae and
Bs51mae1pckA, and B. abortus 2308W and mutant BAB1mae. Each point
represents the mean ± standard error (error bars are within the size of the
symbols) of an experiment performed in technical triplicates. The experiment
was repeated three times with similar results.
phosphoenolpyruvate via PckA. Because these TCA cycle
intermediates could be replenished by condensation of acetyl-
CoA with glyoxylate into malate, we constructed an isocitrate
lyase (AceA; Figure 1) mutant for in vivo studies (see below)
on the role of the glyoxylate bypass. As expected, growth of
this B. suis 513 mutant was identical to that of the parental
strain in peptone-yeast extract, and this mutation had no
effect on the growth in glutamate-lactate-glycerol, glutamate-
glycerol, or lactate-glycerol (results not shown). Similarly,
growth was not affected in media containing peptones (not
shown), even though acetogenic amino acids (leucine, isoleucine,
lysine, phenylalanine, tryptophan, and tyrosine) represent
approximately 20% of the peptone amino acid content.
Brucella suis 513 Requires pckA or ppdK
but Not mae or aceA for Virulence in
Mice
Since analysis of the B. suis 513 mutants in mice requires a
definition of the parameters of virulence of the parental strain in
this laboratory model and these have not been studied previously,
we first inoculated BALB/c mice with 104 and 105 CFU of
B. suis 513. These doses neither caused death nor triggered any
signs of septic shock in the next days, a result similar to those
that are characteristic of the Brucella species infecting domestic
ruminants (Grilló et al., 2012). Therefore, we inoculated BALB/c
mice intraperitoneally with 5 × 104 CFU of B. suis 513 or
B. abortus 2308W and determined the CFU numbers in spleen
in the following weeks (Figure 6A). At week 2 (acute phase of
infection; Grilló et al., 2012), B. suis 513 reached CFU numbers
similar to those obtained with B. abortus. Thereafter, although
CFU numbers were approximately 1.5 logs lower than those
of B. abortus 2308W, B. suis 513 showed persistence typical
of the chronic phase of classical Brucella species (Grilló et al.,
2012). Virulence of B. suis 513 was confirmed in RAW 264.7
macrophages (Figure 6B).
Once we knew these characteristics of B. suis 513, we infected
BALB/c mice with the above-described B. suis 513 mutants
and determined the spleen CFU numbers in the acute and
chronic phase of infection (i.e., 2 and 8 weeks after infection,
respectively). We found that dysfunction of the genes of the
gluconeogenic phosphatases Fbp and GlpX did not result in a
decrease in the CFU numbers in the spleen of mice at either
infection phase (Figure 7). Likewise, neither the pckA nor the
ppdK mutant displayed CFU numbers different from the wild
type control in either infection phase (Figure 7). On the other
hand, the double pckA-ppdK mutant was markedly attenuated
in the chronic phase (p ≤ 0.0001) to the extent that we did not
detect any bacteria in the spleens of two of the five mice in
this group (limit of detection of this method = 3.3 CFU/mL of
the homogenized spleen; Grilló et al., 2012). Altogether, these
results strongly suggest that PckA and PpdK are active during
the infectious process, either alternatively or simultaneously.
In keeping with this interpretation, partial complementation
of the double mutant with plasmid pRH001-ppdK (pAZI-19;
Supplementary Table S1) restored the ability to persist in the
spleens of BALB/c mice (Supplementary Figure S3).
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FIGURE 6 | Multiplication of B. abortus 2308W and B. suis 513 in virulence models. (A) Bacterial multiplication in BALB/c mice. Each point is the mean ± standard
deviation (n = 5) of the log CFU per spleen. (B) Intracellular multiplication in RAW 264.7 macrophages (the B. abortus 2308W virB mutant is used as a control of
attenuation). Values are mean ± standard errors for triplicate infections and the results shown are representative of three independent experiments.
FIGURE 7 | Bacterial loads in the spleens of BALB/c mice at 2 and 8 weeks post-infection of B. suis 513 and mutants Bs51pckA, Bs51ppdK, Bs51pckA1ppdK,
Bs51mae, Bs51mae1pckA, Bs51fbp1glpX, and Bs51aceA. Statistical differences with B. suis 513 were significant at week 8 for Bs51pckA1ppdK
(∗∗∗∗p ≤ 0.0001).
We did not find attenuation for Bs51mae and
Bs51mae1pckA (Figure 7), which indicates that conversion of
malate into pyruvate or oxaloacetate into phosphoenolpyruvate
(Figure 1) is not essential for multiplication of B. suis 513 in
BALB/c mouse spleen cells. Also, we did not observe attenuation
for Bs51aceA (Figure 7), meaning that the glyoxylate shunt is
not essential either for B. suis 513 multiplication in the spleen of
BALB/c mice.
DISCUSSION
Despite repeated isolation from wild rodents in the Caucasus
provinces of the former USSR (Meyer, 1976; Vershilova et al.,
1983; Corbel, 1984), there is little accessible information on
the in vitro nutritional requirements and virulence of B. suis
biovar 5 in standard brucellosis laboratory models. Remarkably,
Russian workers described these isolates as displaying “luxurious”
growth (Lyamkin et al., 1981) and amino acid oxidative abilities
broader than those of B. suis biovar 1 (Lyamkin et al., 1982;
Vershilova et al., 1983), and on these bases they proposed a
new “serobiotype” (B. murium; Banai and Corbel, 2010), which
was not accepted later at a time when the taxonomic status of
B. suis seemed clear to the Brucella Taxonomy Subcommittee
(Meyer, 1976; Vershilova et al., 1983; Corbel, 1984). Consistent
with these reports and the proposal, the reference strain B. suis
513 displayed growth characteristics departing from those of
the classical Brucella species, represented in the present work
by B. abortus 2308W, and were in this regard more similar
to the fast-growing species B. microti. Noteworthy, the natural
hosts of B. suis biovar 5 and B. microti are wild rodents, rather
than domestic livestock (Vershilova et al., 1983; Corbel, 1984;
Scholz et al., 2008) and both are closer to the early diverging
brucellae than B. melitensis, B. abortus, or the other B. suis biovars
(Whatmore, 2009; Soler-Lloréns et al., 2016; Al Dahouk et al.,
2017). Nevertheless, whereas the B. microti strain investigated so
far (CCM 4915) is lethal at doses higher than 104 CFU/mouse and
is rapidly eliminated from the spleen at non-lethal doses (Jiménez
de Bagüés et al., 2010, 2011), 105 CFU of B. suis 513 neither
caused the death of mice nor triggered any signs of septic shock,
and the CFU/spleen profile showed the acute and chronic phases
characteristic of B. abortus, B. melitensis, and among B. suis at
least that of biovar 1. Although in a different animal model, this
observation is in line with those of the Russian workers who
found that the B. suis biovar 5 isolates were similar to B. suis
biovar 1 in pathogenicity and subsequent pathomorphological
changes in guinea pigs (Lyamkin et al., 1983). It has been
pointed out previously that fast growth and lethality correlate
in B. microti CCM 4915 (Jiménez de Bagüés et al., 2010). It
could be that these are two non-causally connected features or
that fast growth results in a rapid increase in Brucella pathogen-
associated molecular pattern (PAMP)-bearing molecules that
could reach lethal levels not attained at the same infectious
dose by the slow-growing strains. Although we cannot rule out
that the fast growth of B. suis 513 does not contribute to any
extent to lower the CFU/spleen counts by bolstering innate
immunity recognition, it is clear that, despite its proximity to
B. microti in growth rates, host, and phylogenomic position,
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B. suis 513 ranks with the classical smooth Brucella species
in lethality and ability to persist in mice (Jiménez de Bagüés
et al., 2011; Grilló et al., 2012). These observations, which should
be confirmed in additional strains, suggest differences in key
PAMP-bearing molecules and, coherent with this hypothesis
is the lack of reactivity of B. microti LPS in Western blot
with monoclonal antibodies recognizing the core-lipid A of
B. melitensis, B. abortus, and B. suis biovars 1, 2, and 5 (Zygmunt
et al., 2012; R. Conde-Álvarez, A. Zúñiga-Ripa, S. Köhler, M.
Iriarte, and I. Moriyón, unpublished observations). Indeed, the
core-lipid A of the classical species bears the PAMP modifications
implicated in reduced innate immunity recognition and lower
septic shock lethality (Lapaque et al., 2005).
Brucella suis 513 being closer to B. abortus 2308W in virulence
in mice and macrophages, but more distant in growth rates in
gluconeogenic media and in phylogenomic position, these two
bacteria represent models suitable for comparing aspects of the
central C metabolism of the core brucellae. The inability of
B. abortus 2308W to grow on simple substrates as the only C
source, most notably glucose, has to be interpreted with care, as
this does not necessarily mean differences in central C pathways.
The same inability has also been noted for the B. melitensis
16M strain kept in the laboratory of the authors, which requires
methionine to grow on glucose and yet is fully virulent (Barbier
et al., 2018). A similar explanation is likely to apply to B. abortus
2308W, as the differences with B. suis 513 in vitro disappear when
glucose is combined with peptone (Figure 2). Indeed, these are
aspects not related to the central C pathways in which there could
be differences among strains with the same reference number
kept in different laboratories, as it is the likely case of B. abortus
2308 variants (Suárez-Esquivel et al., 2016; see also below). The
main differences and similarities that concern the C pathways
specifically investigated here are summarized in Figure 8, and
their potential significance is discussed below.
In vitro, B. suis 513 uses PpdK and PckA for
phosphoenolpyruvate synthesis while B. abortus 2308W
depends only on PpdK. This is likely to reflect the situation
in vivo, because PpdK dysfunction causes attenuation of
B. abortus 2308W in mice (Zúñiga-Ripa et al., 2014) but not in
B. suis 513, in which attenuation occurred only in the double
pckA-ppdK mutant. Although these observations strongly
suggest that PckA is not essential for multiplication in the host
and that, accordingly, it was not positively selected during
evolution, we cannot presently extend this hypothesis to all
core brucellae. On one hand, the genomes of all B. abortus and
B. melitensis sequenced strains show the same pckA frameshift
and subsequent stop codon that results in a truncated protein
of 491 amino acids, and this is also true of the only B. ovis
strain (BOV_2009 strain) sequenced. On the other, the pckA
homologs of B. suis biovar 3 (strain 686), 4 (strain 40), or 5
(strain 513), B. neotomae (strain 5K33), B. ceti (strain B1/94),
and B. pinnipedialis (strains M292/94/1 and M163/99/10)
encode a protein of the same size (536 amino acids) as the
Agrobacterium tumefaciens ortholog (for which there is evidence
of PckA activity; Liu et al., 2005), Ochrobactrum anthropi
and Mesorhizobium loti. Therefore, whereas the genomic,
experimental, and epidemiological data coincide in indicating a
role for PpdK but not for PckA in the virulence of B. abortus and
B. melitensis in ruminants and accidental hosts like humans and
canids, the interpretation of the conservation of pckA in other
brucellae would require studies in the corresponding natural
hosts.
The reasons for the conservation of PpdK over PckA in
B. abortus, B. melitensis, and B. ovis are not obvious. It
may be that, as opposed to the exclusively gluconeogenic
role of PckA, the bidirectional nature of the PpdK catalyzed
pyruvate ↔ phosphoenolpyruvate step makes the latter a more
versatile enzyme (Figure 8). Although the direction of the C flow
remains to be determined, it could indeed change during the
life cycle of the bacteria depending on the substrates available
at different stages, and in such a scenario pckA could become
less useful and eventually superfluous. If TCA were the main
source of precursors in the animal model, B. suis 513 could
obtain phosphoenolpyruvate using Mae and PpdK and/or PckA
(a possibility suggested by the in vitro growth with glutamate;
Figure 5), and loss of PckA in B. abortus would not affect
the Mae and PpdK route (able to supply phosphoenolpyruvate;
Figure 8). This simple picture is in keeping with the attenuation
of B. abortus 2308W mae mutants (Zúñiga-Ripa et al., 2014)
but not with the virulence of the B. suis 513 double mae-pckA
mutant (Figure 7) and the inability of B. abortus 2308W to
grow with glutamate alone in vitro (Table 1 and Figure 3).
A hypothesis that could conciliate all the evidence available is
that B. abortus is complementing the use of malate with a non-
TCA substrate able to provide phosphoenolpyruvate, and that
B. suis 513 uses such a substrate more efficiently, being in this
way independent of malate and oxaloacetate. In this regard lactate
is an attractive candidate because it can provide pyruvate (and
phosphoenolpyruvate using PpdK; Figure 8). Moreover, whereas
B. abortus 2308W (see below) cannot grow on lactate (Figure 3)
and requires glutamate or glycerol as a complement in vitro
(Zúñiga-Ripa et al., 2014), B. suis 513 can use lactate as the only
source of C (Figure 3). Recently, on the basis of the availability of
glutamate, lactate, and glycerol (and erythritol) in genital tissues,
we have speculated that this set of simple C substrates could
mimic the nutritional environment in the host (Letesson et al.,
2017). It is thus conceivable that the dependence of B. abortus on
at least two C sources and the loss of PckA reflect a progressive
adaptation to such a nutritional environment. In this context,
the recent work of Czyz˙ et al. (2017) is also relevant, which
described that B. abortus 2308 requires lactate dehydrogenase
for intracellular survival in THP-1 monocytes. Interestingly,
they also found that infected THP-1 monocytes increase glucose
consumption and lactate production (a Warburg-like effect).
However, the results reported by these authors on the ability of
these bacteria to grow on substrates as the only C source do
not clearly match those described here. Whereas they reported
that a B. abortus 2308 strain was able to metabolize glucose,
lactate, glutamate, and erythritol by measuring the reduction
of a tetrazolium dye in a basal medium containing micromolar
concentrations of arginine, glutamate, cystine, and 0.005% yeast
extract, we did not find evidence for B. abortus 2308W use of
lactate, glutamate, or glucose by a direct measurement of growth
in mineral salts and vitamins. Although the discrepancies are
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FIGURE 8 | Summary of the results of the central C metabolism enzymes in B. abortus 2308W (A) and B. suis 513 (B). Glycolysis, gluconeogenesis, TCA cycle, and
glyoxylate shunt are shown. Black arrows indicate the steps studied in Zúñiga-Ripa et al. (2014) and in this work. Red crosses indicate attenuated mutants, green
crosses specify attenuation when those deletions are combined, blue crosses show steps whose deletion does not affect virulence, broken arrows indicate inactive
genes and question marks indicate undescribed enzymes/pathways (for abbreviations, see Figure 1).
difficult to interpret, and they could be due to the use of different
basal media or strains (see above), it is important to note that
the different ability of 2308W and the 2308 strain used by Czyz˙
et al. (2017) to use lactate in vitro as the only C source do
not contradict the hypothetical importance of lactate in vivo.
The L-lactate permease and L-lactate dehydrogenase required for
the metabolism of lactate (Barbier et al., 2018 and A. Zúñiga-
Ripa, unpublished results) are conserved in all 2308 genomes
sequenced and 2308W can use lactate when other substrates are
added (Zúñiga-Ripa et al., 2014).
Whereas the experimental and genomic data on the role of
PckA and PpdK in the core brucellae agree on the importance
of the latter, this is not the case of AceA, the first enzyme of
the glyoxylate shunt (Figure 1). Substrates such as fatty acids,
some alcohols and esters, waxes, alkenes, and some methylated
compounds enter central C metabolism at the level of acetyl-CoA,
and this pathway enables some bacteria to use them as the sole C
source (Caspi et al., 2018). The pathway may be active in some
brucellae. Using a reporter system, we described that B. abortus
2308W expresses aceA at the beginning of the exponential phase
in peptone-yeast extract-glucose but hardly in glutamate-lactate
glycerol (Zúñiga-Ripa et al., 2014) and, in a proteomic study in
J774 murine macrophages, Al Dahouk et al. (2008) found that
aceA is expressed in B. suis 1330 (biovar 1) 48 h after infection.
Also, Abdou et al. (2017) reported that a B. suis 1330 (biovar 1)
mutant in the regA regulator overexpresses aceA after 3 days
in glutamate-lactate-glycerol in an hypoxic persistence model.
Using the regA mutant, its complemented strain and an aceA
mutant grown in glutamate-lactate-glycerol supplemented with
0.05 mM sodium palmitate and 5 mM ammonium sulfate, these
authors found evidence compatible with an active AceA by testing
the respective cytosolic fractions with phenylhydrazine in the
presence of isocitrate (Abdou et al., 2017). However, the evidence
obtained in the analysis of aceA mutants in virulence models
is not uniform. On one hand, infection of BALB/c mice with a
B. suis 1330 aceA mutant results in lower CFU/spleen in the first
4 weeks but not at later times with respect to a complemented
strain that did not fully restore virulence, and the differences are
not reproduced in the liver (Abdou et al., 2017). On the other,
we observed no attenuation for B. suis 513 or, in a previous
work (Zúñiga-Ripa et al., 2014), for B. abortus 2308W in the
spleens of BALB/c mice in the first 8 weeks. For B. abortus
2308W and B. suis 1330, the discrepancy has been attributed
to strain differences (Abdou et al., 2017) and the results with
B. suis 513 add to the hypothesis of a possible diversity of the
brucellae at this level. There are small differences in the amino
acid sequence of the respective AceA homologs (Supplementary
Figure S4) but these are difficult to interpret without testing the
activity of the purified proteins. It would be striking that AceA
plays a role on virulence in some core brucellae but not in others,
and further research is required to clarify these aspects of the
central C metabolism of these bacteria. Thus far, the ability of
Brucella to grow on fatty acids as the sole C source has not
been explored (Gerhardt, 1958), possibly because of the early
demonstration of their toxicity for B. abortus at very low (10–
0.1 mg/L) concentrations (Boyd and Casman, 1951), which could
hamper studies in vitro.
Both B. abortus 2308W and B. suis 513 double fbp-glpX
mutants were able to grow in gluconeogenic media and, as
discussed before (Zúñiga-Ripa et al., 2014), this suggests a
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hitherto undescribed gluconeogenic pathway (Caspi et al., 2018)
possibly implicating a new type of phosphatase. Search for
such an enzyme has been elusive (M. C. Durand-Steinhauser,
T. Barbier, A. Zúñiga-Ripa, I. Moriyón, and J. J. Letesson,
unpublished results) mainly because of the low activity of the
hypothetical alternative gluconeogenic pathway in B. abortus,
as the poor growth in gluconeogenic media reflects (Figure 3
and Table 1). However, the double fbp-glpX mutant of B. suis
513 displays unscathed gluconeogenic ability in very simple
media, a phenotype that is facilitating this investigation. Research
in progress confirms the hypothesis that a new gluconeogenic
enzyme compatible with a new pathway is in fact active in B. suis
513. Also worth commenting upon is the similar phenotype of
wild type bacteria of B. suis 513 and B. microti CCM 4915 but
not of B. abortus 2308W in gluconeogenic media (Figure 1). This
simple observation suggests that gluconeogenesis is similar in
the former two species, that the pathway is ancestral in the core
brucellae and that there is a reduction of its efficiency in, at least,
B. abortus. Such a reduction would be coherent with a reduced
role or even non-essentiality of the pathway in the natural hosts of
at least B. abortus, a hypothesis to be tested once the new pathway
is fully elucidated.
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